

Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
This document on DLCO (Diffusing Capacity of the Lungs for Carbon Monoxide) provides a concise explanation of the test used to assess how well gases are ex changed in the lungs. It covers the principles behind DLCO measurement, the conditions that can affect lung diffusion capacity—such as pulmonary fibrosis, emphysema, or pulmonary vascular diseases—and how results are interpreted. The notes also highlight the significance of the test in diagnosing and managing respiratory conditions. This resource is ideal for healthcare professionals or students looking to understand and apply DLCO in clinical practice.
Typology: Study notes
1 / 2
This page cannot be seen from the preview
Don't miss anything!


Test Gas used in DLCO Carbon monoxide (CO) - 0.3% Oxygen (O2) - 21% Helium (He) - 0.3% (in traditional method they used 10% of helium) Carbon monoxide - the test gas MOST used in DLCO Reason why carbon monoxide is used in DLCO Its transferability / affinity to hemoglobin (210 times more than oxygen) Molecular weight is same with oxygen Advantages of carbon monoxide % is minimal can be eliminated after the test Factors affecting Diffusing Capacity Ventilation/perfusion relationship. The gas used to measure DLgas must be capable of two physiologic actions: The gas must be capable of diffusing along the A-c pathway. The gas must be capable of being transported by hemoglobin. NOTE: The test must be fulfilled fast Indications Parenchymal lung disease; asbestosis; drug (amiodarone) & sarcoidosis Emphysema & cystic fibrosis Differentiation among chronic bronchitis, emphysema (decrease DLCO) and asthma (normal DLCO) Pulmonary involvement in systemic disease (rheumatoid arthritis, SLE (Systemic lupus erythematosus)) Cardiovascular diseases (pulmonary hypertension) Predict arterial desaturation Disability associated with interstitial lung disease Increase DLCO Left to right CV shunt High altitude Exercise Left sided heart failure Supine body position Early polycythemia - will increase red blood cells that affects V/Q relationship Decrease DLCO - lost of furetion and lost in volume Emphysema Pulmonary resection Asbestosis Lymphangitic spread in CO DLCO methods A. Single Breath Method (Modified Krogh’s Technique) = DLCOSB Body Plethysmography device is used (five way breathing) TECHNIQUE CO and tracer gas analysis relatively simple; 10-sec breath hold ADVANTAGES: Does not require the use of invasive measuring procedures. Analysis of only two gases is required. Test is easily and rapidly performed and can be repeated within a reasonably short period of time.
tidal volumes make VD a smaller portion of the VT. As a result, VD misestimation produces less error. Estimated-Deadspace (Filey) Technique ADVANTAGE Provides a more accurate value for VD than does the assumed VD technique. DISADVANTAGE Requires an arterial blood gas sample. Assumed-Deadspace Technique ADVANTAGE Avoids the need for arterial blood sampling DISADVANTAGE Poses greater risk of VD misestimation (although this does not prevent the procedure from being useful for testing during exercise). Alveolar Gas Sampling Technique ADVANTAGE Avoids errors associated with VD misestimation DISADVANTAGE Possible error in assuming that PetCO is equivalent to the mean PACO value. This is most likely when VTS are small or uneven or when sampling is done during exercise. C. Rebreathing Method = DLCOrb There are two rebreathing method techniques: the reservoir-sampling technique and the washout- sampling technique. Both techniques involve having the subject rebreathe a gas mixture from a bag or balloonlike reservoir. -The gas mixture used contains 0.3% CO and 10% He with the remaining balance of gas being air. -The volume of the reservoir is approximately equal to the volume of the subject's FEV₁. ADVANTAGE: RESERVOIR-SAMPLING TECHNIQUE: In reservoir sampling, the subject rebreathes the gas mixture for a timed period (T_RB) of approximately 30-45 seconds. WASHOUT SAMPLING TECHNIQUE In washout sampling, rebreathing continues until a gas concentration equilibrium is reached between the reservoir and the subject's lungs. The subject is then switched to inhaling air. Exhalation washes the gas mixture from the subject's lungs and allows for the concentrations of CO and He to be analyzed. Rapid- response analyzer systems are used, and the results are recorded The washout-sampling technique is the DLCO method least affected by ventilation/perfusion abnormalities or by changes in the subject's lung volume at the time of testing. Comparison of DLCO methods Single-Breath Methods Simplest of the methods in terms of instrumentation and calculations, but it requires the subject to perform a potentially difficult breathing maneuver. It is moderately affected by ventilation/perfusion abnormalities. Changes in lung volume at the time of measurement can significantly affect test results. Steady-State Methods More natural subject breathing is permitted, but the test procedures are moderately complex. Most likely to be affected by ventilation/perfusion abnormalities. Rebreathing Methods Least affected by ventilation/perfusion abnormalities. The required test procedures and instrumentation are the most complex of all the methods. DIFFERENCE OF VALSALVA and MULLER MANEUVER A Valsalva maneuver reduces pulmonary capillary blood volume and may produce a falsely low DLCO. A Müller maneuver increases pulmonary capillary blood volume and may falsely increase DLCO.